MG
SGHT icon

Michael Gelband’s Sight Sciences SGHT Stock Holding History

Michael Gelband’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73K Buy
+13,470
New +$62K ﹤0.01% 1474

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Michael Gelband's SGHT Position: Q2 2026 in Review

Michael Gelband opened a new position in Sight Sciences (SGHT) in Q2 2026: 13,470 shares worth $73K. The stake represents ﹤0.01% of the portfolio and ranks #1474 among its holdings.

111 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Michael Gelband held 13,470 shares of Sight Sciences worth $73K as of Q2 2026.
  • Sight Sciences was a new Michael Gelband position in Q2 2026.
  • Sight Sciences made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1474 holding.
  • 111 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.